Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Real-World Use Is Focus Of Updated Definition Of Comparative Effectiveness

Executive Summary

The Federal Coordinating Council for Comparative Effectiveness Research has tweaked its definition of comparative effectiveness to place an emphasis on "real-world" use, as well as improving outcomes
Advertisement

Related Content

HHS Plans To Use Four Primary Sources For Online Comparative Effectiveness Research Inventory
Pfizer's Lewis-Hall To Represent Pharma Interests On PCORI Board
One Payer's Perspective On CER: WellPoint Wants Real-World Applicability
One Payer's Perspective On CER: WellPoint Wants Real-World Applicability
Comparative Effectiveness: Pharma Needs To Take Charge, Quintiles Says
Patient-Reported Outcomes May Be Essential To Comparative Research
WellPoint CE Study Results In Coverage Adjustment For Oral Asthma Drugs
AHRQ To Put More Than Half Of Stimulus CER Funding To Evidence Generation
CER Draft Definition Raises No Red Flags, But More Clarity Sought
CER Draft Definition Raises No Red Flags, But More Clarity Sought

Topics

Advertisement
UsernamePublicRestriction

Register

PS051269

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel